WGS peer analysis
GeneDx (WGS) against its competitors: price, today's move, 1-year return and market value side by side.
WGS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AIDX 20/20 Biolabs | $0.19 | -18.35% | – | – |
| BLLN BillionToOne | $115.26 | 2.55% | – | $5.51B |
| CSTL Castle Biosciences | $32.52 | -4.91% | -3.13% | $1.00B |
| FLGT Fulgent Genetics | $23.50 | 25.94% | 3.16% | $656.57M |
| IMDX Insight Molecular Diagnostics | $2.46 | -7.17% | -63.06% | $80.50M |
| MDXH MDxHealth | $0.15 | -3.45% | -96.80% | – |
| MYGN Myriad Genetics | $5.90 | -6.20% | -10.33% | $564.63M |
| NEO NeoGenomics | $16.84 | 2.12% | 61.46% | $2.18B |
| PSNL Personalis | $15.79 | 1.54% | 106.14% | $1.71B |
| WGS GeneDx | $62.75 | -2.50% | -54.15% | $1.87B |
- WGS's peers: AIDX (20/20 Biolabs), BLLN (BillionToOne), CSTL (Castle Biosciences), FLGT (Fulgent Genetics), IMDX (Insight Molecular Diagnostics), MDXH (MDxHealth), MYGN (Myriad Genetics), NEO (NeoGenomics).
Updated 2026-11-07 11:53 UTC